BCL11B predetermines a persister state in breast cancer that is reversed by TNFα
Zhen Qi, Gunsagar Singh Gulati, Rachel Gleyzer…·Michael F. Clarke
This study identifies BCL11B as a determinant of chemoresistance in breast cancer, showing it promotes a persister state that TNFα can reverse.